OGA and neuroblastoma: We altered the O-GlcNAc levels of SH-SY5Y neuroblastoma, HeLa cervical carcinoma, and K562 leukemia cells with TMG and measured O-GlcNAc, OGT, and OGA levels at various time points up to 48 h of TMG treatment.